Source link : https://www.newshealth.biz/health-news/lsd-anxiety-win-pimavanserin-schizophrenia-flop-bright-light-for-depression/
In a phase IIb study, a single dose of an investigational LSD-containing drug (MM120) led to significantly greater reductions in 12-week scores on the Hamilton Anxiety Rating Scale compared with placebo, according to Mind Medicine. These data and prior positive trial findings prompted the FDA to designate the drug as a breakthrough therapy for generalized […]
Author : News Health
Publish date : 2024-03-13 15:00:35
Copyright for syndicated content belongs to the linked Source.
Categories